Trademark: 86936362
Word
MRC
Status
Registered
Status Code
700
Status Date
Tuesday, July 17, 2018
Serial Number
86936362
Registration Number
5520034
Registration Date
Tuesday, July 17, 2018
Mark Type
4000
Filing Date
Thursday, March 10, 2016
Published for Opposition
Tuesday, March 7, 2017

Trademark Owner History
MRC X, LLC - Original Registrant

Classifications
36 strategic consulting services for the life sciences industry, namely, pharmaceuticals, medical devices, bio-pharmaceuticals, biologics, diagnostics, and other life sciences relating to reimbursement services, namely, insurance coverage and payment services
35 strategic consulting services for the life sciences industry, namely, pharmaceuticals, medical devices, bio-pharmaceuticals, biologics, diagnostics, and other life sciences relating to quality systems and clinical evaluation reports for business purposes; strategic marketing advisory services, namely, sales and marketing policies, procedures and pricing for the life sciences industry, including pharmaceuticals, medical devices, bio-pharmaceuticals, biologics, diagnostics, and other life sciences; strategic consulting services for the life sciences industry, namely, pharmaceuticals, medical devices, bio-pharmaceuticals, biologics, diagnostics, and other life sciences relating to medical coding services
45 strategic consulting services for the life sciences industry, namely, pharmaceuticals, medical devices, bio-pharmaceuticals, biologics, diagnostics, and other life sciences relating to FDA regulatory and compliance services, namely, compliance program development
44 strategic consulting services for the life sciences industry, namely, pharmaceuticals, medical devices, bio-pharmaceuticals, biologics, diagnostics, and other life sciences relating to tissue bank services in the nature of tissue auditing, licensing, and registration
42 strategic consulting services for the life sciences industry, namely, pharmaceuticals, medical devices, bio-pharmaceuticals, biologics, diagnostics, and other life sciences relating to FDA regulatory and compliance services, namely, development of policies and procedures

Trademark Events
Jul 17, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jul 17, 2018
Registered-Principal Register
Jun 12, 2018
Notice Of Acceptance Of Statement Of Use E-Mailed
Jun 11, 2018
Allowed Principal Register - Sou Accepted
May 31, 2018
Teas/Email Correspondence Entered
May 30, 2018
Correspondence Received In Law Office
May 30, 2018
Teas Response To Office Action Received
Apr 25, 2018
Teas Extension Received
Dec 1, 2017
Notification Of Non-Final Action E-Mailed
Dec 1, 2017
Non-Final Action E-Mailed
Dec 1, 2017
Su - Non-Final Action - Written
Nov 8, 2017
Notice Of Approval Of Extension Request E-Mailed
Nov 7, 2017
Statement Of Use Processing Complete
Oct 31, 2017
Use Amendment Filed
Nov 7, 2017
Sou Extension 1 Granted
Oct 31, 2017
Sou Extension 1 Filed
Nov 6, 2017
Case Assigned To Intent To Use Paralegal
Oct 31, 2017
Teas Extension Received
Oct 31, 2017
Teas Statement Of Use Received
May 2, 2017
Noa E-Mailed - Sou Required From Applicant
Mar 7, 2017
Official Gazette Publication Confirmation E-Mailed
Mar 7, 2017
Published For Opposition
Feb 15, 2017
Notification Of Notice Of Publication E-Mailed
Feb 2, 2017
Law Office Publication Review Completed
Jan 14, 2017
Approved For Pub - Principal Register
Jan 13, 2017
Teas/Email Correspondence Entered
Jan 13, 2017
Correspondence Received In Law Office
Jan 13, 2017
Assigned To Lie
Dec 15, 2016
Teas Response To Office Action Received
Jun 22, 2016
Notification Of Non-Final Action E-Mailed
Jun 22, 2016
Non-Final Action E-Mailed
Jun 22, 2016
Non-Final Action Written
Jun 21, 2016
Assigned To Examiner
Mar 15, 2016
New Application Office Supplied Data Entered
Mar 14, 2016
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24